Home › Funds › Tri Locum Partners LP › AMRX
Tri Locum Partners LP position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Tri Locum Partners LP reported holding 2,326,733 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$46.9M, representing 9.26% of its reported portfolio and ranking #4 among its reported holdings. Tri Locum Partners LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Tri Locum Partners LP's AMRX position evolved
Tri Locum Partners LP first disclosed a stake in AMRX in Q3 2026 at 2,326,733 shares (US$46.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 2.33M | $46.86M | New |
About AMRX and 13F data
AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 46 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$42.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMRX
- TPG GP A, LLC 12.33M sh · $213.41M · Q2 2026
- Rubric Capital Management LP 10.17M sh · $176.02M · Q2 2026
- Nantahala Capital Management, LLC 2.12M sh · $42.61M · Q3 2026
- Westshore Wealth, LLC 1.37M sh · $23.65M · Q2 2026
- PFM Health Sciences, LP 822.89K sh · $16.57M · Q3 2026
- Phocas Financial Corp. 819.48K sh · $14.19M · Q2 2026
More on Tri Locum Partners LP
FAQ
How long has Tri Locum Partners LP held AMRX?
Tri Locum Partners LP has disclosed AMRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Tri Locum Partners LP's current position in AMRX?
As of Q3 2026, Tri Locum Partners LP holds 2.33M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $46.86M, representing 9.26% of its reported portfolio and ranking #4.
Has Tri Locum Partners LP been buying or selling AMRX?
In the latest 13F filing (Q3 2026), Tri Locum Partners LP newly opened its position in AMRX.
Which other funds hold AMRX?
Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.